Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMALIZUMAB Cause Pulmonary function test abnormal? 273 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 273 reports of Pulmonary function test abnormal have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.4% of all adverse event reports for OMALIZUMAB.

273
Reports of Pulmonary function test abnormal with OMALIZUMAB
0.4%
of all OMALIZUMAB reports
1
Deaths
213
Hospitalizations

How Dangerous Is Pulmonary function test abnormal From OMALIZUMAB?

Of the 273 reports, 1 (0.4%) resulted in death, 213 (78.0%) required hospitalization, and 14 (5.1%) were considered life-threatening.

Is Pulmonary function test abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 273 reports have been filed with the FAERS database.

What Other Side Effects Does OMALIZUMAB Cause?

No adverse event (9,736) Asthma (9,354) Urticaria (9,231) Off label use (9,199) Dyspnoea (8,323) Drug ineffective (6,747) Cough (5,926) Pruritus (5,224) Fatigue (5,053) Malaise (4,820)

What Other Drugs Cause Pulmonary function test abnormal?

ALBUTEROL (399) PREDNISONE (371) MONTELUKAST (332) MEPOLIZUMAB (263) TIOTROPIUM (198) BUDESONIDE (189) OSELTAMIVIR (170) AZITHROMYCIN (169) RUPATADINE (168) CEFTRIAXONE (164)

Which OMALIZUMAB Alternatives Have Lower Pulmonary function test abnormal Risk?

OMALIZUMAB vs OMAVELOXOLONE OMALIZUMAB vs OMBITASVIR OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS

Related Pages

OMALIZUMAB Full Profile All Pulmonary function test abnormal Reports All Drugs Causing Pulmonary function test abnormal OMALIZUMAB Demographics